baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

JTC PLC/ JE00BF4X3P53 /

2024-06-11 5:26:50 PM	Chg. -8.50	Volume	Bid-	Ask-	High	Low
880.00GBX	-0.96%	5,088 Turnover(GBP): 44,881.3000	-Bid Size: -	-Ask Size: -	889.00	875.00

GlobeNewswire 06-11 Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference

GlobeNewswire 06-11 GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor Pitch Conference

GlobeNewswire 06-11 Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI...

GlobeNewswire 06-10 Palisade Bio to Present at the Virtual Investor Pitch Conference

GlobeNewswire 06-10 AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference

GlobeNewswire 06-10 Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human ...

GlobeNewswire 06-03 AIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series

GlobeNewswire 06-03 Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-I...

GlobeNewswire 05-31 AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering

GlobeNewswire 05-31 Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire 05-28 Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizuma...

GlobeNewswire 05-23 Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis ...

GlobeNewswire 05-22 GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positi...

GlobeNewswire 05-21 GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for t...

GlobeNewswire 05-21 Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent...

GlobeNewswire 05-20 AIM ImmunoTech to Participate in Two Upcoming Investor Conferences

GlobeNewswire 05-20 GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important...

GlobeNewswire 05-16 AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 05-15 Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Cor...

GlobeNewswire 05-15 Aeterna Zentaris Reports First Quarter 2024 Financial Results

GlobeNewswire 05-14 Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

GlobeNewswire 05-14 GRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company Showcase

GlobeNewswire 05-14 Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 05-13 Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...

GlobeNewswire 05-13 GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update

JTC PLC/ JE00BF4X3P53 /

If you wish to receive reply to your feedback, please provide your email address.